|
|
Volumn 139, Issue , 2014, Pages 167-183
|
|
Safety assurance for biologics manufactured in mammalian cell cultures: a multitiered strategy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
ADVERSE DRUG REACTION;
ANIMAL;
ARTICLE;
BATCH CELL CULTURE;
DRUG CONTAMINATION;
DRUG INDUSTRY;
EQUIPMENT;
EQUIPMENT DESIGN;
EQUIPMENT FAILURE;
HEALTH CARE QUALITY;
HUMAN;
INTERNATIONAL COOPERATION;
MAMMAL;
PRODUCT SAFETY;
STANDARD;
ANIMALS;
BATCH CELL CULTURE TECHNIQUES;
BIOLOGICAL PRODUCTS;
CONSUMER PRODUCT SAFETY;
DRUG CONTAMINATION;
DRUG INDUSTRY;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
EQUIPMENT DESIGN;
EQUIPMENT FAILURE ANALYSIS;
HUMANS;
INTERNATIONALITY;
MAMMALS;
QUALITY ASSURANCE, HEALTH CARE;
|
|
EID: 84902684527
PISSN: 07246145
EISSN: None
Source Type: Journal
DOI: 10.1007/10_2013_213 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
